HKSE - Delayed Quote HKD
China Regenerative Medicine International Limited (8158.HK)
0.420
-0.005
(-1.18%)
As of April 22 at 9:37:04 AM GMT+8. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
6,338
6,338
-12,434
-3,022
-399,145
Investing Cash Flow
-262
-262
-2,590
9,271
326,964
Financing Cash Flow
-7,364
-7,364
7,322
-1,389
67,369
End Cash Position
3,334
3,334
1,849
9,929
4,767
Capital Expenditure
-274
-274
-2,591
-809
--
Issuance of Capital Stock
--
--
--
--
99,183
Issuance of Debt
7,088
7,088
20,185
9,659
20,295
Repayment of Debt
-4,294
-4,294
-1,725
-1,725
-55,172
Free Cash Flow
6,064
6,064
-15,025
-3,831
-399,145
12/31/2020 - 7/18/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade